Sign In
Home
Adalimumab
Get your patient on
Adalimumab
(Adalimumab-Fkjp)
injectable - 50 mg/ml auto-injector 0.8 ml
Check coverage
See the specific documentation and step therapies required.
Check coverage
Medication interactions
See all drug-to-drug interactions for this medication.
Check interactions
Prescribing info
PubMedâ„¢ news
Adalimumab prescribing information
Data source
Data source
Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Report Adverse Event
Check medication interactions
Review interactions as part of your prescribing workflow
Check interactions
Adalimumab PubMedâ„¢ news
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
5 most recent articles for Adalimumab
,
view all articles on PubMedâ„¢
Journal Article • 2026 May
Efficacy of Adalimumab Therapy for Non-Infectious Uveitis in Japanese Patients: Methotrexate Concomitance Across Different Uveitis Etiologies and the Effect of Dose Spacing.
Journal Article • 2026 May
Correspondence on 'Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study' by Mysler et al.
Journal Article • 2026 May
Pulmonary tuberculosis and tuberculous pleuropericarditis in a patient with pyoderma gangrenosum treated with adalimumab: a case report.
Journal Article • 2026 May
Ocular Inflammation as a Risk Factor for Anti-Adalimumab Antibodies in Patients with Autoimmune Diseases Treated with Adalimumab.
Journal Article • 2026 May
Systemic Infliximab Is Efficacious for the Control of Pediatric Uveitis Including in Adalimumab-Refractory Patients.
Show the latest PubMedâ„¢ articles for Adalimumab
I certify that I'm a U.S. healthcare provider